| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/25/1991 | CA2030770A1 Thrombolytic agents |
| 05/24/1991 | WO1991008195A1 N-(1-(2-carboxyethyl)cycloalkyl carbonyl)-beta-alanine derivatives for pharmaceutical use |
| 05/24/1991 | CA2067223A1 Therapeutic agents |
| 05/22/1991 | EP0428423A2 Aryloxy alkyl benzenes, processes for their preparation and pharmaceutical compositions containing them |
| 05/22/1991 | EP0428267A2 Erythropoietin isoforms |
| 05/22/1991 | EP0428182A1 Dextran derivatives having anticoagulant and anticomplementary properties, their preparation and their biological applications |
| 05/22/1991 | EP0427779A1 Use of dextrin derivatives for the treatment of acidic conditions |
| 05/22/1991 | EP0427765A1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs |
| 05/22/1991 | EP0237545B1 Production of pluripotent granulocyte colony-stimulating factor |
| 05/22/1991 | CN1051564A Polysaccharides, anti-coagulant and anticomplement obtained from untreated fucanes of alga, and process of preparation thereof |
| 05/22/1991 | CN1051554A Indenoindole compounds ii |
| 05/22/1991 | CN1012642B Process for preparation of sulfamoylbenzoic acid derivatives |
| 05/21/1991 | US5017588 Anticoagulants |
| 05/21/1991 | CA1284330C 2,4-diphenyl-1,3-dioxanes |
| 05/18/1991 | WO1991007490A1 Protein complexes having factor viii:c activity and production thereof |
| 05/18/1991 | WO1991007378A1 Cycloalkyl-substituted glutaramide diuretic agents |
| 05/18/1991 | CA2135744A1 Protein complexes having factor viii:c activity and production thereof |
| 05/18/1991 | CA2068728A1 Protein complexes having factor viii:c activity and production thereof |
| 05/18/1991 | CA2067197A1 Cycloalkyl-substituted glutaramide diuretic agents |
| 05/17/1991 | CA2030004A1 Tetrahydronaphthalene derivatives and preparation thereof |
| 05/16/1991 | WO1991006632A1 Inhibition of padgem-mediated cell binding |
| 05/16/1991 | DE3937607A1 Verwendung eines antikoagulanz zur behandlung von tumorerkrankungen Use of an anticoagulant in the treatment of tumor diseases |
| 05/15/1991 | EP0427189A1 Modified forms of human erythropoietin and DNA sequences encoding genes which can express them |
| 05/15/1991 | EP0259468B1 Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs |
| 05/15/1991 | CN1051359A Imidazo (4,5-b) quinolinyloxyalkanoic acid amides with enhanced water solubility |
| 05/15/1991 | CN1051354A Substituted cycloalano(b)dihydroindole-and-indolesulphonamides |
| 05/14/1991 | US5015657 2-halogen-substituted N-indolylethyl-sulphonamides and inhibiting platelet aggregation and antagonizing thromboxane A2 therewith |
| 05/14/1991 | US5015648 Use of a thromboxane receptor antagonist in pregnancy-induced hypertension and related conditions |
| 05/12/1991 | WO1991007187A1 Agent for neutralising the procoagulant activity associated with tumor cells |
| 05/12/1991 | CA2068312A1 Agent for neutralising the procoagulant activity associated with tumor cells |
| 05/10/1991 | WO1991007438A1 A method for isolating factor viii |
| 05/08/1991 | EP0426180A2 Imidazo[4,5-b] quinolinyloxyalkanoic acid amides with enhanced water solubility |
| 05/08/1991 | EP0425946A2 Iso- and heterocyclic phenylsulphonamides |
| 05/08/1991 | EP0425906A2 Substituted cycloalkano[b]dihydroindol- and -indolsulfonamides |
| 05/08/1991 | EP0425584A1 Prostaglandin-derivatives having antithrombotic activity |
| 05/08/1991 | EP0425536A1 Nonglycosylated human interleukin-3 compositions |
| 05/08/1991 | EP0374252A4 Injection-type hemostatic composition |
| 05/08/1991 | CA2029457A1 Modified forms of human erythropoietin and dna sequences encoding genes which can express them |
| 05/07/1991 | US5013756 Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same |
| 05/07/1991 | US5013724 Process for the sulfation of glycosaminoglycans, the sulfated glycosaminoglycans and their biological applications |
| 05/07/1991 | US5013718 Method for treating iron overload using EPO |
| 05/07/1991 | US5013558 Pharmaceutical treatments for cerebral and neuronal diseases |
| 05/03/1991 | CA2029057A1 Antithrombotic iso- and heterocyclic phenylsulphonamides |
| 05/02/1991 | WO1991005867A1 Erythropoietin isoforms |
| 05/02/1991 | WO1991005795A1 Stem cell factor |
| 05/02/1991 | WO1991005549A1 Benzoheterocyclic compounds |
| 05/02/1991 | EP0425362A2 Furosemide salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them |
| 05/02/1991 | EP0425212A2 Cyclic anti-aggregatory peptides |
| 05/02/1991 | EP0425134A1 Condensed pyrrolo derivatives, process for their preparation and pharmaceutical compositions containing them |
| 05/02/1991 | EP0424901A1 Dihydropyridine derivatives and pharmaceutical compositions |
| 05/02/1991 | EP0424722A2 Substituted (quinolin-2-yl-methoxy)phenyl-thioureas |
| 05/02/1991 | EP0205564B1 Method for the production of erythropoietin |
| 05/02/1991 | CA2027935A1 Imidazo [4,5-b] quinolinyloxyalkanoic acid amides with enhanced water solubility |
| 05/01/1991 | CN1051038A Benzoheterocyclic compounds |
| 05/01/1991 | CA2028621A1 Antithrombotic substituted cycloalkano[b]dihydroindole- and -indole-sulphonamides |
| 04/30/1991 | US5011952 Phospholipase A2 inhibitor |
| 04/30/1991 | US5011930 Antilipemic agents, anticoagulants |
| 04/30/1991 | US5011825 Treatment of hypertension, diabetes, edema |
| 04/27/1991 | CA2028394A1 Dihydropyridine derivatives and pharmaceutical compositions |
| 04/26/1991 | CA2028314A1 Substituted (quinolin-2-yl-methoxy)phenyl-carbonylureas |
| 04/25/1991 | CA2028326A1 Furosemide salts, process for the preparation thereof, application as medicaments and pharmaceutical compositions containing them |
| 04/24/1991 | EP0424351A2 Modified heparin cofactor II |
| 04/24/1991 | EP0424214A1 5-[2-[[2-Amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5H)-benzothiazepine-4-one derivatives, their preparation and their use in therapy |
| 04/24/1991 | EP0423980A1 Stem cell factor |
| 04/24/1991 | EP0423805A2 Condensed purine derivatives |
| 04/23/1991 | US5010073 Use of liposomes as carriers for metalloporphyrins |
| 04/23/1991 | US5010064 Anticoagulants |
| 04/23/1991 | US5010063 Antithrombotic agent, anticoagulant, reduces hemorrhage |
| 04/23/1991 | US5010059 Pharmaceutical products and lactosyl compounds |
| 04/23/1991 | CA1283357C Thrombosis treatment with fibrinolytics and prostacyclins |
| 04/22/1991 | CA2028042A1 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
| 04/21/1991 | CA2028082A1 Modified heparin cofactor ii |
| 04/19/1991 | WO1991005565A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
| 04/19/1991 | CA2070393A1 Biosynthetic constructs of tgf-beta |
| 04/18/1991 | WO1991005048A1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use |
| 04/18/1991 | WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 04/18/1991 | WO1991004740A1 Combined preparation with anti-thrombotic action |
| 04/18/1991 | CA2027738A1 5-{2-[(2-amino-2-oxoethyl) (methyl)amino]ethyl}-2,3-dihydro-3-hydroxy-2-(4-methoxyphen yl)-1,5(5h)-benzothiazepin-4-one derivatives, their preparation and their application in therapy |
| 04/17/1991 | EP0422938A1 Fibrinogen receptor antagonists |
| 04/17/1991 | EP0422937A1 Fibrinogen receptor antagonists |
| 04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| 04/17/1991 | CN1050721A Radiolabeled anticoagulant peptides |
| 04/17/1991 | CN1050720A Anticoagulant peptides |
| 04/17/1991 | CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells |
| 04/17/1991 | CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent |
| 04/17/1991 | CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells |
| 04/16/1991 | US5008400 Bicyclic aminoacids as intermediates |
| 04/16/1991 | US5008253 Sulfoamino derivatives of chondroitin sulfates of dermatan sulfate and of hyaluronic acid and their pharmacological properties |
| 04/16/1991 | US5008247 Polysulfuric acid esters of bis-aldonamides and their derivatives, process for their preparation and medicaments |
| 04/16/1991 | US5008240 Polypeptide with amino acid sequence of cartilage inducing factor A or B |
| 04/16/1991 | CA1283098C Depolymerized hexosaminoglucan sulfates endowed with an antithrombotic, fibrinolytic, antiinflammatory activity, their process of preparation and related pharmaceutical compositions |
| 04/16/1991 | CA1283048C Therapeutic agent for treating hematopoietic diseases |
| 04/16/1991 | CA1283047C Stabilized plasminogen activator precursor and method of producing the same |
| 04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |
| 04/14/1991 | CA2027315A1 Fibrinogen receptor antagonists |
| 04/14/1991 | CA2027314A1 Fibrinogen receptor antagonists |
| 04/12/1991 | CA2026629A1 Heterocyclic compounds and production thereof |
| 04/11/1991 | CA2027076A1 Process for preparation of 4-(4-isobutylphenyl)-butyr-aldehyde and its use for the preparation of (-)-4(2-chlorophenyl)-2[2-(4-isobutylphenyl)-ethyl]-6,9-dim ethyl-6h-thieno[3,2-f]1,2,4]-triazolo[4,3][1,4]diazepine |
| 04/10/1991 | EP0421918A1 Pharmaceutical compositions |